Other
orciprenaline
Safety score · 0–100
Caution
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
About
Orciprenaline is a cosmetic ingredient used in product formulations. Exercise caution due to limited available safety data.
Orciprenaline (metaproterenol) is a non-selective beta-adrenergic agonist used as a bronchodilator for asthma and COPD, with pharmacological activity similar to isoprenaline. It carries risks of cardiovascular side effects including tachycardia. As a prescription pharmaceutical substance with no cosmetic regulatory history, it is excluded from EU cosmetics regulation scope. No REACH registration or SCCS evaluation exists for cosmetic applications.
Known concerns
- Beta-adrenergic bronchodilator drug incompatible with cosmetics
- Cardiovascular side effects including tachycardia
- No EU cosmetics authorization or SCCS evaluation
- Outside scope of cosmetics regulation
References
EU CosIng database
European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.
Related others
Check your shelf
Find orciprenaline in your products.
Scan any cosmetic product with LuxSense to see if it contains orciprenaline and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.